MinutePhraseM to Science · 4 years agoCRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improvedwww.nejm.orgexternal-linkmessage-square0fedilinkarrow-up16arrow-down10
arrow-up16arrow-down1external-linkCRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improvedwww.nejm.orgMinutePhraseM to Science · 4 years agomessage-square0fedilink
